NCT03633591 - A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

October 22, 2018

Study Completion Date

October 22, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

Tolcapone

Multiple doses of tolcapone tablets in the fasted state

DRUG

Tolcapone Modified Release Prototype

A single dose of tolcapone modified release prototype in the fasted state

DRUG

Tolcapone Divided Dose

Tolcapone (suspension) in equal divided doses in the fasted state

DRUG

Tolcapone Modified Release Prototype

A single dose of tolcapone modified release prototype (optionally two doses or fed state of prior MR prototype)

Trial Locations (1)

Quotient Sciences, Ruddington